Profile data is unavailable for this security.
About the company
Ondine Biomedical Inc. is a Canadian life sciences company. The Company specializes in light-activated antimicrobial therapies (photo disinfection) for the prevention and treatment of infections, including those caused by multidrug-resistant organisms. The Company has a pipeline of investigational products, based on its proprietary photo disinfection technology, in various stages of development. The Company's nasal photo disinfection system has a CE mark in Europe and is approved in Canada, Australia, Mexico and several other countries under the name Steriwave. In the United States, it has been granted Qualified Infectious Disease Product designation and Fast Track status by the FDA and is undergoing clinical trials for regulatory approval. Its products beyond nasal photo disinfection include therapies for a variety of medical indications such as chronic sinusitis, ventilator-associated pneumonia, serious burns, chronic wounds, central line bloodstream infections and other indications.
- Revenue in GBP (TTM)1.20m
- Net income in GBP-13.03m
- Incorporated1996
- Employees43.00
- LocationOndine Biomedical Inc888-1100 Melville StVANCOUVER V6E 4A6CanadaCAN
- Phone+1 (604) 669-0555
- Fax+1 (604) 669-0555
- Websitehttps://ondinebio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cellbxhealth PLC | 2.62m | -15.78m | 11.39m | 119.00 | -- | 0.2759 | -- | 4.34 | -0.0489 | -0.0489 | 0.0081 | 0.0362 | 0.1028 | 0.5939 | 1.46 | 22,050.42 | -61.80 | -41.90 | -72.78 | -46.81 | 62.27 | 18.55 | -601.37 | -1,051.13 | 2.63 | -470.57 | 0.2387 | -- | 30.92 | -- | 29.34 | -- | -- | -- |
| Genedrive PLC | 954.00k | -5.23m | 12.70m | 43.00 | -- | 4.51 | -- | 13.32 | -0.0092 | -0.0092 | 0.0017 | 0.0023 | 0.1984 | -- | 1.80 | 22,186.05 | -108.81 | -77.52 | -153.92 | -106.30 | -- | -- | -548.32 | -1,016.12 | 1.64 | -- | 0.00 | -- | 90.42 | -2.07 | 26.06 | -- | -10.48 | -- |
| Renalytix PLC | 2.24m | -15.22m | 14.29m | 45.00 | -- | -- | -- | 6.38 | -0.0606 | -0.0606 | 0.0082 | -0.0158 | 0.4547 | 7.64 | 4.54 | -- | -309.18 | -83.70 | -- | -107.25 | 40.00 | 28.27 | -680.00 | -1,519.31 | 1.17 | -24.57 | 6.38 | -- | 31.06 | -- | 55.14 | -- | -- | -- |
| Abingdon Health PLC | 8.43m | -3.42m | 16.95m | 121.00 | -- | 2.47 | -- | 2.01 | -0.0176 | -0.0176 | 0.0435 | 0.0274 | 1.17 | 9.71 | 3.87 | 69,661.16 | -47.42 | -54.04 | -70.70 | -85.91 | 44.32 | 30.37 | -40.51 | -110.07 | 1.58 | -- | 0.1625 | -- | 37.39 | 9.99 | -168.69 | -- | -26.92 | -- |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m | 20.89m | 214.00 | -- | 1.28 | -- | 0.4622 | -0.1275 | -0.1275 | 0.5038 | 0.1826 | 1.03 | 2.00 | 5.91 | 211,215.00 | -25.96 | -6.05 | -33.03 | -7.45 | 44.39 | 46.62 | -25.32 | -7.01 | 1.11 | 2.42 | 0.441 | -- | 1.65 | 16.56 | -148.04 | -- | 39.05 | -- |
| Aptamer Group PLC | 1.20m | -2.42m | 23.60m | 31.00 | -- | 12.61 | -- | 19.62 | -0.0014 | -0.0014 | 0.0007 | 0.0007 | 0.4294 | 6.27 | 4.35 | 38,806.45 | -86.53 | -- | -154.00 | -- | 48.13 | -- | -201.50 | -- | 1.48 | -84.63 | 0.2622 | -- | 39.88 | -- | 18.05 | -- | -- | -- |
| Aoti Inc | 47.64m | 1.76m | 39.05m | 80.00 | 18.25 | 2.95 | 11.15 | 0.8197 | 0.0201 | 0.0201 | 0.4786 | 0.1245 | 1.32 | 2.17 | 4.65 | -- | 4.87 | -- | 6.54 | -- | 88.13 | -- | 3.69 | -- | 2.54 | 2.81 | 0.5269 | -- | 32.88 | -- | 78.55 | -- | -- | -- |
| Delta Gold Technologies PLC | -100.00bn | -100.00bn | 42.25m | -- | -- | 71.98 | -- | -- | -- | -- | -- | 0.0091 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Ondine Biomedical Inc | 1.20m | -13.03m | 53.43m | 43.00 | -- | 115.16 | -- | 44.47 | -0.0358 | -0.0358 | 0.0032 | 0.0009 | 0.3447 | 0.5771 | 8.03 | -- | -373.83 | -- | -4,807.85 | -- | 65.77 | -- | -1,084.66 | -- | 0.7948 | -- | 0.4333 | -- | 70.32 | -- | -32.51 | -- | -- | -- |
| Creo Medical Group PLC | 2.20m | 12.60m | 60.84m | 133.00 | 4.99 | 0.999 | 4.38 | 27.65 | 0.0296 | 0.0272 | 0.0056 | 0.1477 | 0.0319 | -0.8034 | 0.3308 | 16,541.35 | 18.25 | -29.25 | 20.62 | -35.89 | 45.45 | 47.22 | 572.73 | -176.82 | 4.75 | -69.50 | 0.0645 | -- | 0.00 | 212.28 | -17.30 | -- | -18.58 | -- |
| SDI Group PLC | 69.29m | 4.59m | 82.82m | 504.00 | 18.42 | 1.61 | 9.13 | 1.20 | 0.043 | 0.043 | 0.6497 | 0.4923 | 0.7692 | -- | 5.78 | 137,484.10 | 5.12 | 7.08 | 5.81 | 8.87 | -- | 63.93 | 6.65 | 8.60 | 1.19 | 5.75 | 0.3363 | 0.00 | 0.5027 | 21.99 | -5.84 | 8.99 | 11.55 | -- |
| Inspecs Group PLC | 192.83m | -3.31m | 84.39m | 1.65k | -- | 0.9471 | 9.03 | 0.4376 | -0.0326 | -0.0806 | 1.90 | 0.8764 | 0.9138 | 2.31 | 7.71 | 116,586.50 | -1.57 | -2.16 | -2.31 | -3.13 | 51.86 | 49.60 | -1.72 | -2.79 | 0.8847 | 1.73 | 0.3969 | -- | -2.48 | 32.80 | -362.19 | -- | 4.97 | -- |
| EKF Diagnostics Holdings PLC | 50.22m | 6.12m | 111.41m | 297.00 | 19.11 | 1.62 | 10.14 | 2.22 | 0.0135 | 0.0135 | 0.1109 | 0.1597 | 0.6209 | 3.16 | 7.34 | 165,745.90 | 7.98 | 5.79 | 8.77 | 6.76 | 49.79 | 49.42 | 12.86 | 8.62 | 3.47 | -- | 0.0152 | -- | -4.59 | 2.25 | 165.39 | 11.16 | 3.02 | -- |
| Holder | Shares | % Held |
|---|---|---|
| M&G Investment Management Ltd.as of 11 Feb 2026 | 67.60m | 13.04% |
| Janus Henderson Investors UK Ltd.as of 30 Jun 2025 | 50.27m | 9.70% |
| Chelverton Asset Management Ltd.as of 30 Jun 2025 | 16.00m | 3.09% |
| Premier Fund Managers Ltd.as of 31 Oct 2025 | 5.17m | 1.00% |
